ATE111484T1 - Verbindungen zur verhinderung von thrombose. - Google Patents

Verbindungen zur verhinderung von thrombose.

Info

Publication number
ATE111484T1
ATE111484T1 AT89311739T AT89311739T ATE111484T1 AT E111484 T1 ATE111484 T1 AT E111484T1 AT 89311739 T AT89311739 T AT 89311739T AT 89311739 T AT89311739 T AT 89311739T AT E111484 T1 ATE111484 T1 AT E111484T1
Authority
AT
Austria
Prior art keywords
gly
glu
cys
asp
indicates
Prior art date
Application number
AT89311739T
Other languages
English (en)
Inventor
Roy Sawyer
Christopher Powell-Jones
Anthony Atkinson
Asgar Electricwala
Original Assignee
Biopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopharm Ltd filed Critical Biopharm Ltd
Application granted granted Critical
Publication of ATE111484T1 publication Critical patent/ATE111484T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89311739T 1988-11-11 1989-11-13 Verbindungen zur verhinderung von thrombose. ATE111484T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888826428A GB8826428D0 (en) 1988-11-11 1988-11-11 Antithrombin

Publications (1)

Publication Number Publication Date
ATE111484T1 true ATE111484T1 (de) 1994-09-15

Family

ID=10646705

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89311739T ATE111484T1 (de) 1988-11-11 1989-11-13 Verbindungen zur verhinderung von thrombose.

Country Status (16)

Country Link
US (1) US5472942A (de)
EP (1) EP0373767B1 (de)
JP (1) JP2865345B2 (de)
KR (1) KR0153774B1 (de)
AT (1) ATE111484T1 (de)
AU (1) AU636857B2 (de)
CA (1) CA2002924C (de)
DE (1) DE68918246T2 (de)
DK (1) DK173077B1 (de)
FI (1) FI912240A0 (de)
GB (1) GB8826428D0 (de)
HU (1) HUT62016A (de)
IE (1) IE64652B1 (de)
RU (1) RU2050160C1 (de)
WO (1) WO1990005143A1 (de)
ZA (1) ZA898655B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721098A (en) * 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
GB9007879D0 (en) * 1990-04-06 1990-06-06 Biopharm Ltd Treatment of thrombotic events
IL101062A0 (en) * 1991-02-28 1992-11-15 Erba Carlo Spa Anti-thrombin polypeptides and their preparation
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US7534567B2 (en) * 1992-03-04 2009-05-19 The Regents Of The University Of California Detection of nucleic acid sequence differences by comparative genomic hybridization
GB9309509D0 (en) * 1993-05-07 1993-06-23 Merck Patent Gmbh Thrombin inhibitors
IT1266561B1 (it) * 1993-07-22 1997-01-09 Mini Ricerca Scient Tecnolog Analoghi di un polipeptide anti-trombinico e procedimento per la loro preparazione
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US6008320A (en) * 1995-04-27 1999-12-28 Korea Advanced Institute Of Science And Technology Elastase inhibitor and process for preparing the same
TWI238827B (en) * 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
US6077825A (en) * 1997-03-13 2000-06-20 Auburn University Antithrombin protein and DNA sequences from black fly
RU2242992C2 (ru) * 1999-05-03 2004-12-27 Астразенека Аб Фармацевтический препарат, содержащий ингибитор карбоксипептидазы u и ингибитор тромбина
RU2170101C1 (ru) * 2000-02-17 2001-07-10 Общество с ограниченной ответственностью Научно-производственное предприятие "БИОНОКС" Средство для лечения воспалительных заболеваний
WO2005079474A2 (en) * 2004-02-17 2005-09-01 The Regents Of The University Of California Detection of nucleic acid sequence differences by comparative genomic hybridization
US8685462B1 (en) 2012-09-17 2014-04-01 Biopep Solutions, Inc. Whole, leech saliva product and applications thereof
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法
CN115677850B (zh) * 2021-07-24 2024-03-08 王大勇 具备较强抗凝血活性的医蛭基因突变水蛭素及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
US5139944A (en) * 1985-08-10 1992-08-18 Biophram (Uk) Limited Collagen-specific enzyme with platelet aggregation inhibition properties
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
EP0333356A3 (de) * 1988-03-04 1990-12-19 Biogen, Inc. Hirudin-Peptide
EP0347376B1 (de) * 1988-06-11 1994-03-23 Ciba-Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung

Also Published As

Publication number Publication date
FI912240A7 (fi) 1991-05-09
DK87891D0 (da) 1991-05-10
JP2865345B2 (ja) 1999-03-08
RU2050160C1 (ru) 1995-12-20
JPH04502907A (ja) 1992-05-28
CA2002924A1 (en) 1990-05-11
DE68918246D1 (de) 1994-10-20
GB8826428D0 (en) 1988-12-14
KR900701832A (ko) 1990-12-04
EP0373767B1 (de) 1994-09-14
AU4522589A (en) 1990-05-28
WO1990005143A1 (en) 1990-05-17
DK173077B1 (da) 1999-12-20
FI912240A0 (fi) 1991-05-09
ZA898655B (en) 1990-08-29
KR0153774B1 (ko) 1998-10-15
IE64652B1 (en) 1995-08-23
AU636857B2 (en) 1993-05-13
HUT62016A (en) 1993-03-29
EP0373767A1 (de) 1990-06-20
DK87891A (da) 1991-06-21
CA2002924C (en) 1999-08-03
HU896934D0 (en) 1991-07-29
US5472942A (en) 1995-12-05
DE68918246T2 (de) 1995-02-16

Similar Documents

Publication Publication Date Title
ATE111484T1 (de) Verbindungen zur verhinderung von thrombose.
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ATE277078T1 (de) N-terminal modifizierte polypeptide, und herstellungsprozess
EP0617126A3 (de) Polypeptid, fähig zur Inhibierung der Bindung zwischen menschliches IL-6 und dessen Rezeptor.
ATE92107T1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
EP0357750A4 (en) Urethane-protected amino acid-n-carboxyanhydrides
EP0370989A3 (de) Menschlicher Gefässpermeabilitätsfaktor
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
GR3026369T3 (en) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
TW207950B (de)
EP0225020A3 (de) Peptide, welche in der Sequenz Einheiten von Aminosäureresten 17 bis 24 von VIP enthalten
NO892267D0 (no) Hirudinderivater med forsinket virkning.
HU895788D0 (en) Process for producing peptides and medical products containing them
DE68921229D1 (de) Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein.
FI93843B (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
DK0378432T3 (da) Peptider, deres anvendelse til inhibering af modningen af T-lymfocytter og aktiviteten af makrofager samt fremgangsmåder til deres fremstilling
DE3751398D1 (de) Substrat-Peptide.
DK0717048T3 (da) Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse
EP0248231A3 (en) Pharmacologically active peptides
MX9800686A (es) Nueva proteina hmw humana mp52s.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee